Home Press Releases Percutaneous Coronary Intervention (PCI) Devices Market Size Worth $11.4 Billion By 2027 | CAGR: 7.1%

Percutaneous Coronary Intervention (PCI) Devices Market Size Worth $11.4 Billion By 2027 | CAGR: 7.1% |

The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion by 2027 according to a new study by Polaris Market Research. The report “Percutaneous Coronary Intervention Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Coronary Catheters, Coronary Guidewires, Coronary Stents, and Accessories); By End Use (Hospitals, Ambulatory Surgical Centers, and Catherization Labs); By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Coronary artery disease (CAD) is causing most of deaths globally. The factors contributing to the disease include sedentary lifestyle, smoking, obesity, hereditary factors and alcohol usage. The mortality rate of CAD has been tremendously increasing grabbing the attention for researchers and clinicians globally, With the technological advancements in stent technologies, design of the guide wires, advent of next generation  coronary catheters (percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA) balloon catheters ), and the availability of coronary guide wires (steel based, nitinol based ) increased the treatment scope of the coronary heart diseases.

 

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-sample

 

The emergence of dedicated catheterization labs in high income countries is also pivotal factor influencing the growth of the PCI devices market. The next generation Cath labs offers advanced services and performs interventional therapeutic procedures such as PCI, PTCA, epicardial ablations of ventricular tachycardia, aortic valve replacements and mitral valve repairs. Additionally, they also perform interventional cardiac electrophysiological procedures, pacemaker implantation and cardiac defibrillator implantation. The number of PCI procedures and other cardiac interventions is substantially increasing with the increase in the cardiovascular diseases globally.

 

To increase the performance of multi-specialty hospitals, many government and private hospitals are setting up catheterization labs for improved service offerings. This concept is gaining popularity for PCI procedures in Canada, the US, the UK, Germany, and other western countries. The factors favoring its growth include the conversion of physician’s office to alternate hospital providers, surgeons’ relationship with the manufacturers to eliminate the need of general practitioner officers (GPO), and the expansion of services provided by the hospitals.

 

Market participants such as Abbott, B. Braun, ASAHI INTECC Company Limited, Biosensors International Group, Ltd, Boston Scientific Corporation, C. R. Bard, BIOTRONIK, Comed BV, Cook, Meril Lifesciences, Cordis, Medtronic PLC, Merit Medical System, and Terumo Corporation are some of the key players operating in the percutaneous coronary intervention (PCI) devices market. Key vendors are investing huge amounts into their R&D and introducing new technologies and launching new products to stay competitive in this market. Several products were launched in the recent past with the latest next generation technology which caters the growing needs of the physician and the patients.

 

Polaris Market research has segmented the percutaneous coronary intervention (PCI) devices market report on the basis of product, end-use and region

Percutaneous Coronary Intervention Devices Product Outlook (Revenue – USD Million, 2016 – 2027)

  • Coronary Catheters
  • Coronary Guidewires
  • Coronary Stents
  • Accessories

Percutaneous Coronary Intervention Devices End Use Outlook (Revenue – USD Million, 2016 – 2027)

  • Hospitals
  • Ambulatory Surgical Centers
  • Catherization Labs

Percutaneous Coronary Intervention Devices Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

License and Pricing

Buy Now

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing

Request For Customization

Please specify your research requirement and get customized report


Regional AnalysisSegmentation AnalysisIndustry OutlookCompetitive Analysis
By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

By using this form you agree with the storage and handling of your data by this website.